Clinical Trial

Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Clinical study of high concentration ganciclovir eye drops in the treatment of cytomegalovirus retinitis
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-19.
Trial Details
NCT Number NCT05911503
Lead Sponsor Tianjin Medical University
Conditions Cytomegalovirus Retinitis, Ganciclovir Eye Drops
Enrollment 15 participants
Start Date 2023-07-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2023-06-23